I agree that this site is using cookies. You can find further informations here.
X
Horiike, Atsushi
143  results:
Search for persons X
?
1

Nivolumab receptor occupancy on effector regulatory T cells..:

Hosonuma, Masahiro ; Hirasawa, Yuya ; Kuramasu, Atsuo...
Cancer Science.  115 (2024)  3 - p. 752-762 , 2024
Link: https://doi.org/10.1111/..
 
?
2

Isobutyric acid enhances the anti-tumour effect of anti-PD-..:

Murayama, Masakazu ; Hosonuma, Masahiro ; Kuramasu, Atsuo...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Subsequent treatment for locally advanced non-small-cell lu..:

Hasegawa, Tsukasa ; Ariyasu, Ryo ; Tanaka, Hisashi...
Cancer Chemotherapy and Pharmacology.  92 (2023)  1 - p. 29-37 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Case Report: Combined pembrolizumab, 5-fluorouracil, and ci..:

Suzuki, Risako ; Hamada, Kazuyuki ; Ohkuma, Ryotaro...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

Turicibacter and Acidaminococcus predict immune-related adv..:

Hamada, Kazuyuki ; Isobe, Junya ; Hattori, Kouya...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
6

Novel quantitative immunohistochemical analysis for evaluat..:

Ohkuma, Ryotaro ; Miura, Sakiko ; Muto, Satoshi...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

Clinical efficacy of amrubicin in patients with small cell ..:

Uematsu, Shinya ; Kitazono, Satoru ; Tanaka, Hisashi...
Thoracic Cancer.  14 (2022)  2 - p. 168-176 , 2022
Link: https://doi.org/10.1111/..
 
?
8

A case of bronchial asthma as an immune-related adverse eve..:

Hamada, Kazuyuki ; Yoshimura, Kiyoshi ; Oshinomi, Kazuhiko...
Medicine.  101 (2022)  2 - p. e28339 , 2022
Link: https://doi.org/10.1097/..
 
?
9

The PD-L1/22C3 assay for primary lung cancer is feasible fo..:

Suganuma, Hiromitsu ; Kusumoto, Sojiro ; Manabe, Ryo...
The Showa University Journal of Medical Sciences.  34 (2022)  2 - p. 64-77 , 2022
Link: https://doi.org/10.15369..
 
?
10

Clinical efficacy of dacomitinib in rechallenge setting for..:

Tanaka, Hisashi ; Sakamoto, Hiroaki ; Akita, Takahiro...
Thoracic Cancer.  13 (2022)  10 - p. 1471-1478 , 2022
Link: https://doi.org/10.1111/..
 
?
11

A case report on severe nivolumab-induced adverse events si..:

Hirasawa, Yuya ; Yoshimura, Kiyoshi ; Matsui, Hiroto...
Medicine.  100 (2021)  23 - p. e25774 , 2021
Link: https://doi.org/10.1097/..
 
?
12

Increased Plasma Soluble PD-1 Concentration Correlates with..:

Ohkuma, Ryotaro ; Ieguchi, Katsuaki ; Watanabe, Makoto...
Biomedicines.  9 (2021)  12 - p. 1929 , 2021
Link: https://doi.org/10.3390/..
 
?
13

First‐line pembrolizumab vs chemotherapy in metastatic non‐..:

Satouchi, Miyako ; Nosaki, Kaname ; Takahashi, Toshiaki...
Cancer Science.  112 (2021)  12 - p. 5000-5010 , 2021
Link: https://doi.org/10.1111/..
 
?
14

A high number of PD-L1+ CD14+ monocytes in peripheral blood..:

Ando, Kiyohiro ; Hamada, Kazuyuki ; Shida, Midori...
Cancer Immunology, Immunotherapy.  70 (2020)  2 - p. 337-348 , 2020
Link: https://doi.org/10.1007/..
 
?
15

Retracted: First‐line pembrolizumab vs chemotherapy in meta..:

Satouchi, Miyako ; Nosaki, Kaname ; Takahashi, Toshiaki...
Cancer Science.  111 (2020)  12 - p. 4480-4489 , 2020
Link: https://doi.org/10.1111/..
 
1-15